Lupin gets FDA nod for generic Cialis
Lupin has received the Food and Drug Administration’s clearance for its generic Cialis (tadalafil tablets). It will be available in dosage strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg.
The product is the generic of Eli Lilly’s Cialis tablets, indicated for the treatment of erectile dysfunction, the signs and symptoms of benign prostatic hyperplasia and erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia.
The product had a market value of approximately $1.7 billion, according to December 2018 IQVIA data.
The product is the generic of Eli Lilly’s Cialis tablets, indicated for the treatment of erectile dysfunction, the signs and symptoms of benign prostatic hyperplasia and erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia.
The product had a market value of approximately $1.7 billion, according to December 2018 IQVIA data.